Arganat 250Mg/2.5Ml Inf

Arganat 250Mg/2.5Ml Inf belongs to the anticoagulant medication class known as a direct thrombin inhibitor. It is used to manage heparin-induced thrombocytopenia (HIT), a rare, life-threatening complication of heparin therapy. Besides this, it works as an anticoagulant in adult patients with or at risk for HIT undergoing percutaneous coronary intervention (PCI).

Arganat 250Mg/2.5Ml Inf contains 'Argatroban,' which is a direct thrombin inhibitor. It works by reversibly binding to thrombin, a substance in the blood that causes blood clotting. This prevents the formation of harmful clots in the body.

Arganat 250Mg/2.5Ml Inf is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. The most common side effects in HIT patients were dyspnea, hypotension, fever, diarrhoea, sepsis, and cardiac arrest. The most common side effects in PCI patients were chest pain, hypotension, back pain, nausea, vomiting and headache. These side effects may vary individually. Most of these side effects do not require medical attention and will resolve gradually. However, you are advised to talk to your doctor if you experience these side effects persistently.

Before taking the Arganat 250Mg/2.5Ml Inf, let your doctor know about all your medical conditions, sensitivities, and all medications you are using. Arganat 250Mg/2.5Ml Inf is not recommended during pregnancy unless indicated by the doctor. Discontinue nursing or drug, taking into account the importance of the drug to the mother. It is recommended not to consume any alcoholic beverages to rule out any possibility of side effects. Safety and effectiveness have not been established in the paediatric population.

Arganat 250Mg/2.5Ml Inf contains 'Argatroban,' which is a direct thrombin inhibitor. It works by reversibly binding to thrombin, a substance in the blood that causes blood clotting. This prevents the formation of harmful clots in the body.

HIT patients:

• Dyspnea
• Hypotension
• Fever
• Diarrhoea
• Sepsis
• Cardiac Arrest

PCI patients:

• Chest Pain
• Hypotension
• Back Pain
• Nausea
• Vomiting
• Headache

Inform your doctor about all of your health problems (especially active bleeding), allergic reactions (food or medicine sensitivities), and drugs you are using (especially Thrombolytic agents such as Urokinase) before taking the Arganat 250Mg/2.5Ml Inf. When pregnant, Arganat 250Mg/2.5Ml Inf should not be used unless specifically advised by a physician. So, inform your doctor if you are pregnant or planning to. Discontinue nursing or medicine, taking into account the importance of the drug to the mother. Do not consume any other medications while on therapy unless prescribed by the doctor.

Drug-Drug Interactions: Arganat 250Mg/2.5Ml Inf may interact with other anticoagulant medications (e.g. fondaparinux, enoxaparin, clopidogrel, rivaroxaban).

Drug-Food Interactions: No interactions found/established.

Drug-Disease Interactions: The use of Arganat 250Mg/2.5Ml Inf is contraindicated in the presence of active major bleeding. 

• FONDAPARINUX
• ENOXAPARIN
• CLOPIDOGREL
• RIVAROXABAN

• Consume a well-balanced and healthy diet that includes vegetables, fruits, whole grains, legumes, omega-3-rich foods, and lean protein sources.
• Keep your weight under control with a BMI of 19.5-24.9.
• Exercise on a regular basis to keep your body and mind healthy.
• Avoid chronic stress.
• Smoking and consuming alcohol should be avoided.
• To reduce the risk of bleeding, avoid activities such as contact sports and the use of sharp objects such as nail cutters and razors.

Heparin-induced thrombocytopenia (HIT) is a serious consequence that can arise in patients who have been exposed to any kind or dose of heparin. HIT is distinguished by a decrease in platelet count and a hypercoagulable condition. HIT patients may potentially develop thromboembolic consequences, which can result in considerable morbidity and mortality.